Skip to content

Efficacy of a drug named probiotics in treating acute diarrhoea in adults

Efficacy of Lactobacillus sporogenes in treating acute diarrhoea in adults-randomised control study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013360
Enrollment
204
Registered
2018-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- acute diarrhoea

Interventions

Intervention1: probiotics: lactobacillus sporogenes 120 million spores 1 tablet contain 120 million spores of lactobacillus sporogenes . 1 tablet thrice daily for 7 days Control Intervention1: placebo

Sponsors

Dr Meera Baby John
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients above 14years who have acute diarrhea

Exclusion criteria

Exclusion criteria: acute diarrhea who also have a serious complication ( renal failure , metabolic acidosis , severe dehydration , hypovolemic shock , heart failure) History of allergy to lactobacillus spp. H/o diarrhoea caused by amoeba (as evidenced by demonstration of motile trophozoites with blood in stool)colorectal cancer (as diagnosed by a per rectal examinationand/or endoscopic procedures where necessary). Known allergy to study drugs Patients who are already on probiotics

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of lactobacillus sporogenes in reducing the duration of diarrhoea in adults compared to placebo and it will be assessed for 7 daysTimepoint: To determine the efficacy of lactobacillus sporogenes in reducing the duration of diarrhoea in adults compared to placebo and it will be assessed for 7 days

Secondary

MeasureTime frame
To establish the efficacy of lactobacillus sporogenes in reducing the frequency of loose stools,abdominal pain and hospital stay compared to placebo in adults with diarrhoeaTimepoint: 2 years

Countries

India

Contacts

Public ContactMeera baby john

Pondicherry Institute of medical sciences

kurien123@gmail.com9790014548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026